CWC
SNY icon

Carolinas Wealth Consulting’s Sanofi SNY Stock Holding History

Carolinas Wealth Consulting’s Portfolio SNY Stock Details SNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-212
Closed -$11.8K – 800
2025
Q1 		$11.8K Buy
212
+7
+3% +$379 ﹤0.01% 510
2024
Q4 		$9.89K Sell
205
-21
-9% -$1.07K ﹤0.01% 547
2024
Q3 		$13K Hold
226
– – ﹤0.01% 527
2024
Q2 		$11K Buy
226
+108
+92% +$5.21K ﹤0.01% 542
2024
Q1 		$5.72K Sell
118
-13
-10% -$635 ﹤0.01% 628
2023
Q4 		$6.51K Sell
131
-27
-17% -$1.32K ﹤0.01% 592
2023
Q3 		$7.15K Buy
158
+16
+11% +$853 ﹤0.01% 562
2023
Q2 		$7.65K Buy
142
+55
+63% +$2.96K ﹤0.01% 628
2023
Q1 		$4.74K Sell
87
-236
-73% -$11.5K ﹤0.01% 689
2022
Q4 		$15.6K Buy
+323
New +$14.2K ﹤0.01% 542

Other funds holding SNY

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Barrow, Hanley, Mewhinney & Strauss
Barrow, Hanley, Mewhinney & Strauss Dallas, Texas $30.5B AUM 29.95% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Carolinas Wealth Consulting's SNY Position: Q2 2025 in Review

Carolinas Wealth Consulting sold out of Sanofi (SNY) in Q2 2025, closing a stake of 212 shares — an estimated $11.8K sold.

Carolinas Wealth Consulting first reported a position in SNY in Q4 2022 and held it in 10 quarters. The position peaked at $15.6K in Q4 2022. 730 funds tracked by Wall St. Rank hold SNY as of Q2 2025.

  • Carolinas Wealth Consulting reported no remaining Sanofi position as of Q2 2025 after selling out during the quarter.
  • Carolinas Wealth Consulting sold 212 Sanofi shares in Q2 2025, an estimated $11.8K.
  • Carolinas Wealth Consulting first reported a position in Sanofi in Q4 2022 and held it in 10 quarters.
  • Carolinas Wealth Consulting's Sanofi position peaked at $15.6K in Q4 2022.
  • 730 funds tracked by Wall St. Rank held Sanofi as of Q2 2025.

Based on Carolinas Wealth Consulting's 13F filing for Q2 2025.